Immunotherapy in Multiple Myeloma
Multiple myeloma is a complex disease and immune dysfunction has been known to play an important role in the disease pathogenesis, progression, and drug resistance. Recent efforts in drug development have been focused on immunotherapies to modify the MM disease process. Here, we summarize the emergi...
Main Authors: | Cinnie Yentia Soekojo, Melissa Ooi, Sanjay de Mel, Wee Joo Chng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/3/601 |
Similar Items
-
Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
by: Louis-Pierre Girard, et al.
Published: (2022-06-01) -
Editorial: Immunotherapy in Multiple Myeloma
by: Nicola Giuliani, et al.
Published: (2019-08-01) -
The Evolution of Cancer Immunotherapy
by: Meshaal Khan, et al.
Published: (2021-06-01) -
Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
by: Panagiotis Samaras, et al.
Published: (2019-04-01) -
Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01)